BioCentury
ARTICLE | Company News

Takeda, Roivant Sciences deal

June 13, 2016 7:00 AM UTC

Takeda and Roivant launched Myovant Sciences Ltd. Takeda granted the newco exclusive, worldwide rights outside of Japan and other Asian countries to relugolix ( TAK-385) and worldwide rights to RVT-...